Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 16 August, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 500770 | NSE: TATACHEM

Tata Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 7:57 pm

Market Cap 23,782 Cr.
Current Price 934
High / Low 1,247/756
Stock P/E51.6
Book Value 847
Dividend Yield1.18 %
ROCE3.96 %
ROE1.20 %
Face Value 10.0
PEG Ratio-29.85

Quick Insight

Tata Chemicals Ltd's current intrinsic value analysis, with a share price of 941 and a market cap of 23,986 Cr., reflects a high P/E ratio of 52.1, indicating potentially overvalued stock. The company's ROE stands at a modest 1.20%, while ROCE is at 3.96%, suggesting room for improvement in capital efficiency. With a healthy OPM of 17% and a substantial net profit of 387 Cr., Tata Chemicals demonstrates operational strength. However, the high level of borrowings at ₹7,072 Cr. warrants attention, especially with an ICR of 5.91x. In conclusion, while the company shows profitability and operational efficiency, managing debt levels will be crucial for sustained growth and shareholder value.

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Tata Chemicals Ltd

Competitors of Tata Chemicals Ltd

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Caprolactam Chemicals Ltd 20.0 Cr. 43.6 65.0/37.5 10.50.00 %0.48 %13.7 % 10.0
Standard Industries Ltd 117 Cr. 18.1 31.1/17.5 18.65.79 %7.81 %10.5 % 5.00
Gujarat Alkalies & Chemicals Ltd 4,042 Cr. 550 900/484 7720.00 %0.32 %1.11 % 10.0
GHCL Ltd 5,345 Cr. 556 779/5118.65 3642.16 %24.2 %18.6 % 10.0
Tata Chemicals Ltd 23,782 Cr. 934 1,247/75651.6 8471.18 %3.96 %1.20 % 10.0
Industry Average6,853.60 Cr464.1240.18382.681.55%7.11%8.15%9.17

All Competitor Stocks of Tata Chemicals Ltd

Quarterly Result

MetricJun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
Sales 3,9954,2394,1484,4074,2183,9983,7303,4753,7893,9993,5903,5093,719
Expenses 2,9803,3193,3173,4423,1753,1913,1883,0323,2153,3813,1563,1823,070
Operating Profit 1,0159208319651,043807542443574618434327649
OPM % 25%22%20%22%25%20%15%13%15%15%12%9%17%
Other Income 7110230866718798-861116152-1029138
Interest 8086107133123145132130133145148137147
Depreciation 213218227234229234246271273277280293280
Profit before tax 793718527684758615262-819284348-4-74360
Tax % 20%5%19%-1%23%20%26%3%33%23%425%-34%12%
Net Profit 637680425692587495194-841190267-21-49316
EPS in Rs 23.1224.6515.3527.8320.8816.806.20-33.365.897.61-2.08-2.209.89

Last Updated: August 1, 2025, 9:30 pm

Below is a detailed analysis of the quarterly data for Tata Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

  • For Sales, as of Jun 2025, the value is 3,719.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,509.00 Cr. (Mar 2025) to 3,719.00 Cr., marking an increase of 210.00 Cr..
  • For Expenses, as of Jun 2025, the value is 3,070.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3,182.00 Cr. (Mar 2025) to 3,070.00 Cr., marking a decrease of 112.00 Cr..
  • For Operating Profit, as of Jun 2025, the value is 649.00 Cr.. The value appears strong and on an upward trend. It has increased from 327.00 Cr. (Mar 2025) to 649.00 Cr., marking an increase of 322.00 Cr..
  • For OPM %, as of Jun 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 9.00% (Mar 2025) to 17.00%, marking an increase of 8.00%.
  • For Other Income, as of Jun 2025, the value is 138.00 Cr.. The value appears strong and on an upward trend. It has increased from 29.00 Cr. (Mar 2025) to 138.00 Cr., marking an increase of 109.00 Cr..
  • For Interest, as of Jun 2025, the value is 147.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 137.00 Cr. (Mar 2025) to 147.00 Cr., marking an increase of 10.00 Cr..
  • For Depreciation, as of Jun 2025, the value is 280.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 293.00 Cr. (Mar 2025) to 280.00 Cr., marking a decrease of 13.00 Cr..
  • For Profit before tax, as of Jun 2025, the value is 360.00 Cr.. The value appears strong and on an upward trend. It has increased from -74.00 Cr. (Mar 2025) to 360.00 Cr., marking an increase of 434.00 Cr..
  • For Tax %, as of Jun 2025, the value is 12.00%. The value appears to be increasing, which may not be favorable. It has increased from -34.00% (Mar 2025) to 12.00%, marking an increase of 46.00%.
  • For Net Profit, as of Jun 2025, the value is 316.00 Cr.. The value appears strong and on an upward trend. It has increased from -49.00 Cr. (Mar 2025) to 316.00 Cr., marking an increase of 365.00 Cr..
  • For EPS in Rs, as of Jun 2025, the value is 9.89. The value appears strong and on an upward trend. It has increased from -2.20 (Mar 2025) to 9.89, marking an increase of 12.09.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 5:34 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Sales 15,88517,20414,87310,34610,27010,33710,35710,20012,62216,78915,42114,887
Expenses 15,20015,30512,7778,2496,9268,5388,4118,69310,31712,96912,57412,934
Operating Profit 6861,9002,0962,0973,3441,7991,9451,5062,3053,8202,8471,953
OPM % 4%11%14%20%33%17%19%15%18%23%18%13%
Other Income -1541832102932627856,480254486218-521287
Interest 579461525297326354342367303406530563
Depreciation 4714635265125185686667598068929801,123
Profit before tax -5191,1591,2551,5802,7631,6617,4166341,6822,740816554
Tax % 56%30%20%22%2%17%3%31%16%11%47%30%
Net Profit -8118021,0061,2342,7021,3877,2284361,4052,434435387
EPS in Rs -40.5023.4130.2438.9895.4945.37274.9710.0649.3790.9310.529.22
Dividend Payout % -25%53%33%28%23%28%4%99%25%19%143%119%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)198.89%25.44%22.66%118.96%-48.67%421.12%-93.97%222.25%73.24%-82.13%-11.03%
Change in YoY Net Profit Growth (%)0.00%-173.45%-2.77%96.30%-167.63%469.79%-515.09%316.22%-149.01%-155.37%71.09%

Tata Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:-1%
5 Years:8%
3 Years:6%
TTM:-1%
Compounded Profit Growth
10 Years:-8%
5 Years:-48%
3 Years:-40%
TTM:-41%
Stock Price CAGR
10 Years:16%
5 Years:26%
3 Years:-6%
1 Year:-10%
Return on Equity
10 Years:12%
5 Years:5%
3 Years:5%
Last Year:1%

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:09 pm

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital 255255255255255255255255255255255255
Reserves 5,3115,2976,6007,65310,84712,08612,64314,03517,99819,46621,98621,339
Borrowings 8,3938,3799,0907,0726,1086,1307,7026,9337,0246,2965,5637,072
Other Liabilities 6,1276,8728,4028,6078,6488,3987,0737,1158,5668,9238,9079,084
Total Liabilities 20,08620,80224,34623,58725,85826,86927,67328,33733,84334,94036,71137,750
Fixed Assets 11,00711,35913,43112,64412,78713,55115,35615,26116,04417,09217,86119,600
CWIP 4681893503334097748351,0941,6682,4102,2171,913
Investments 4414432,1882,7872,8405,6154,2855,8167,6837,4489,7399,144
Other Assets 8,1718,8118,3777,8229,8226,9297,1986,1678,4487,9906,8947,093
Total Assets 20,08620,80224,34623,58725,85826,86927,67328,33733,84334,94036,71137,750

Below is a detailed analysis of the balance sheet data for Tata Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

  • For Equity Capital, as of Mar 2025, the value is 255.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 255.00 Cr..
  • For Reserves, as of Mar 2025, the value is 21,339.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21,986.00 Cr. (Mar 2024) to 21,339.00 Cr., marking a decrease of 647.00 Cr..
  • For Borrowings, as of Mar 2025, the value is 7,072.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 5,563.00 Cr. (Mar 2024) to 7,072.00 Cr., marking an increase of 1,509.00 Cr..
  • For Other Liabilities, as of Mar 2025, the value is 9,084.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8,907.00 Cr. (Mar 2024) to 9,084.00 Cr., marking an increase of 177.00 Cr..
  • For Total Liabilities, as of Mar 2025, the value is 37,750.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36,711.00 Cr. (Mar 2024) to 37,750.00 Cr., marking an increase of 1,039.00 Cr..
  • For Fixed Assets, as of Mar 2025, the value is 19,600.00 Cr.. The value appears strong and on an upward trend. It has increased from 17,861.00 Cr. (Mar 2024) to 19,600.00 Cr., marking an increase of 1,739.00 Cr..
  • For CWIP, as of Mar 2025, the value is 1,913.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,217.00 Cr. (Mar 2024) to 1,913.00 Cr., marking a decrease of 304.00 Cr..
  • For Investments, as of Mar 2025, the value is 9,144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9,739.00 Cr. (Mar 2024) to 9,144.00 Cr., marking a decrease of 595.00 Cr..
  • For Other Assets, as of Mar 2025, the value is 7,093.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,894.00 Cr. (Mar 2024) to 7,093.00 Cr., marking an increase of 199.00 Cr..
  • For Total Assets, as of Mar 2025, the value is 37,750.00 Cr.. The value appears strong and on an upward trend. It has increased from 36,711.00 Cr. (Mar 2024) to 37,750.00 Cr., marking an increase of 1,039.00 Cr..

Notably, the Reserves (21,339.00 Cr.) exceed the Borrowings (7,072.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity +2,3381,2742,3323,5311,8701,5811,7802,0371,6452,9713,0161,761
Cash from Investing Activity +-563-663-463-9852,714-1,927-2,285-1,147-817-1,149-605-1,667
Cash from Financing Activity +-1,865-1,087-1,802-2,341-2,089-1,712-129-1,456-755-2,076-2,49429
Net Cash Flow-91-477682052,494-2,058-634-56573-254-83123

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow678.00-7.00-7.00-5.00-3.00-5.00-6.00-5.00-5.00-3.00-3.00-6.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days747388744651565056574547
Inventory Days96137119244304315347257318282341324
Days Payable11913899232307269302256338289320318
Cash Conversion Cycle52721078643971005135506653
Working Capital Days11-431-427-2-10227-2929-22-21
ROCE %3%11%11%10%16%9%36%4%8%12%8%4%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters37.98%37.98%37.98%37.98%37.98%37.98%37.98%37.98%37.98%37.98%37.98%37.98%
FIIs13.62%14.99%14.92%14.43%14.59%14.47%14.16%14.07%13.84%13.76%13.56%13.60%
DIIs19.89%19.14%19.42%18.97%19.77%19.91%20.91%20.44%19.97%19.91%20.34%21.68%
Government0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%
Public28.48%27.86%27.64%28.60%27.64%27.63%26.92%27.49%28.18%28.31%28.08%26.72%
No. of Shareholders6,22,7916,22,1246,14,0166,33,3596,21,4836,55,1666,51,2746,70,0667,58,5727,45,5947,30,5286,87,065

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
HDFC Mid-Cap Opportunities Fund - Regular Plan 4,260,000 0.74 437.954,260,0002025-04-22 13:31:130%
Kotak Flexicap Fund - Regular Plan 3,750,000 0.87 385.523,750,0002025-04-22 03:17:280%
Kotak Equity Opportunities Fund - Regular Plan 2,064,884 1.16 212.282,064,8842025-04-22 17:25:360%
Nippon India Growth Fund 1,561,427 0.66 160.521,561,4272025-04-22 17:25:360%
DSP Mid Cap Fund 1,382,053 0.86 142.081,382,0532025-04-22 03:17:280%
DSP Equity Opportunities Fund 717,459 0.69 73.76717,4592025-04-22 17:25:360%
HDFC Large and Mid Cap Fund - Regular Plan 508,000 0.33 52.22508,0002025-04-22 03:17:280%
Quant Active Fund 217,000 0.27 22.31217,0002025-04-22 03:17:280%
Edelweiss Arbitrage Fund 149,600 0.19 15.38149,6002025-04-22 03:17:280%
Kotak Multicap Fund 143,500 0.17 14.75143,5002025-04-22 03:17:280%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23Mar 22Mar 21Mar 20
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 10.5290.9549.3710.06275.02
Diluted EPS (Rs.) 10.5290.9549.3710.06275.02
Cash EPS (Rs.) 52.82130.4377.9145.91309.96
Book Value[Excl.RevalReserv]/Share (Rs.) 906.43809.49751.80594.25536.12
Book Value[Incl.RevalReserv]/Share (Rs.) 906.43809.49751.80594.25536.12
Revenue From Operations / Share (Rs.) 604.75658.39495.33400.27406.43
PBDIT / Share (Rs.) 122.86158.43100.4968.0988.70
PBIT / Share (Rs.) 84.43123.4568.8538.2962.55
PBT / Share (Rs.) 29.88107.4556.5323.8749.13
Net Profit / Share (Rs.) 14.3995.4546.2716.11283.81
NP After MI And SOA / Share (Rs.) 10.5190.8649.3510.06274.95
PBDIT Margin (%) 20.3124.0620.2817.0121.82
PBIT Margin (%) 13.9618.7513.909.5615.38
PBT Margin (%) 4.9416.3211.415.9612.08
Net Profit Margin (%) 2.3714.499.344.0269.82
NP After MI And SOA Margin (%) 1.7313.809.962.5167.64
Return on Networth / Equity (%) 1.2011.746.881.7954.32
Return on Capital Employeed (%) 7.0110.436.554.087.71
Return On Assets (%) 0.726.603.710.9025.30
Long Term Debt / Equity (X) 0.130.280.200.360.26
Total Debt / Equity (X) 0.220.300.370.380.41
Asset Turnover Ratio (%) 0.420.480.400.140.14
Current Ratio (X) 1.051.661.231.491.11
Quick Ratio (X) 0.631.150.901.110.84
Inventory Turnover Ratio (X) 1.071.221.220.500.44
Dividend Payout Ratio (NP) (%) 166.4113.7220.25109.305.47
Dividend Payout Ratio (CP) (%) 35.739.9012.3427.595.00
Earning Retention Ratio (%) -66.4186.2879.75-9.3094.53
Cash Earning Retention Ratio (%) 64.2790.1087.6672.4195.00
Interest Coverage Ratio (X) 5.919.958.464.726.61
Interest Coverage Ratio (Post Tax) (X) 3.347.044.912.124.02
Enterprise Value (Cr.) 32847.3031130.1031228.9624062.009753.04
EV / Net Operating Revenue (X) 2.131.852.472.360.94
EV / EBITDA (X) 10.487.7112.2013.874.31
MarketCap / Net Operating Revenue (X) 1.791.481.971.880.54
Retention Ratios (%) -66.4186.2779.74-9.3094.52
Price / BV (X) 1.241.261.361.340.44
Price / Net Operating Revenue (X) 1.791.481.971.880.54
EarningsYield 0.010.090.050.011.23

After reviewing the key financial ratios for Tata Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 10.52. This value is within the healthy range. It has decreased from 90.95 (Mar 23) to 10.52, marking a decrease of 80.43.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 10.52. This value is within the healthy range. It has decreased from 90.95 (Mar 23) to 10.52, marking a decrease of 80.43.
  • For Cash EPS (Rs.), as of Mar 24, the value is 52.82. This value is within the healthy range. It has decreased from 130.43 (Mar 23) to 52.82, marking a decrease of 77.61.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 906.43. It has increased from 809.49 (Mar 23) to 906.43, marking an increase of 96.94.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 906.43. It has increased from 809.49 (Mar 23) to 906.43, marking an increase of 96.94.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 604.75. It has decreased from 658.39 (Mar 23) to 604.75, marking a decrease of 53.64.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 122.86. This value is within the healthy range. It has decreased from 158.43 (Mar 23) to 122.86, marking a decrease of 35.57.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 84.43. This value is within the healthy range. It has decreased from 123.45 (Mar 23) to 84.43, marking a decrease of 39.02.
  • For PBT / Share (Rs.), as of Mar 24, the value is 29.88. This value is within the healthy range. It has decreased from 107.45 (Mar 23) to 29.88, marking a decrease of 77.57.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 14.39. This value is within the healthy range. It has decreased from 95.45 (Mar 23) to 14.39, marking a decrease of 81.06.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 10.51. This value is within the healthy range. It has decreased from 90.86 (Mar 23) to 10.51, marking a decrease of 80.35.
  • For PBDIT Margin (%), as of Mar 24, the value is 20.31. This value is within the healthy range. It has decreased from 24.06 (Mar 23) to 20.31, marking a decrease of 3.75.
  • For PBIT Margin (%), as of Mar 24, the value is 13.96. This value is within the healthy range. It has decreased from 18.75 (Mar 23) to 13.96, marking a decrease of 4.79.
  • For PBT Margin (%), as of Mar 24, the value is 4.94. This value is below the healthy minimum of 10. It has decreased from 16.32 (Mar 23) to 4.94, marking a decrease of 11.38.
  • For Net Profit Margin (%), as of Mar 24, the value is 2.37. This value is below the healthy minimum of 5. It has decreased from 14.49 (Mar 23) to 2.37, marking a decrease of 12.12.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.73. This value is below the healthy minimum of 8. It has decreased from 13.80 (Mar 23) to 1.73, marking a decrease of 12.07.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 1.20. This value is below the healthy minimum of 15. It has decreased from 11.74 (Mar 23) to 1.20, marking a decrease of 10.54.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 7.01. This value is below the healthy minimum of 10. It has decreased from 10.43 (Mar 23) to 7.01, marking a decrease of 3.42.
  • For Return On Assets (%), as of Mar 24, the value is 0.72. This value is below the healthy minimum of 5. It has decreased from 6.60 (Mar 23) to 0.72, marking a decrease of 5.88.
  • For Long Term Debt / Equity (X), as of Mar 24, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.28 (Mar 23) to 0.13, marking a decrease of 0.15.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.22. This value is within the healthy range. It has decreased from 0.30 (Mar 23) to 0.22, marking a decrease of 0.08.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.42. It has decreased from 0.48 (Mar 23) to 0.42, marking a decrease of 0.06.
  • For Current Ratio (X), as of Mar 24, the value is 1.05. This value is below the healthy minimum of 1.5. It has decreased from 1.66 (Mar 23) to 1.05, marking a decrease of 0.61.
  • For Quick Ratio (X), as of Mar 24, the value is 0.63. This value is below the healthy minimum of 1. It has decreased from 1.15 (Mar 23) to 0.63, marking a decrease of 0.52.
  • For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.07. This value is below the healthy minimum of 4. It has decreased from 1.22 (Mar 23) to 1.07, marking a decrease of 0.15.
  • For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 166.41. This value exceeds the healthy maximum of 50. It has increased from 13.72 (Mar 23) to 166.41, marking an increase of 152.69.
  • For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 35.73. This value is within the healthy range. It has increased from 9.90 (Mar 23) to 35.73, marking an increase of 25.83.
  • For Earning Retention Ratio (%), as of Mar 24, the value is -66.41. This value is below the healthy minimum of 40. It has decreased from 86.28 (Mar 23) to -66.41, marking a decrease of 152.69.
  • For Cash Earning Retention Ratio (%), as of Mar 24, the value is 64.27. This value is within the healthy range. It has decreased from 90.10 (Mar 23) to 64.27, marking a decrease of 25.83.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 5.91. This value is within the healthy range. It has decreased from 9.95 (Mar 23) to 5.91, marking a decrease of 4.04.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.34. This value is within the healthy range. It has decreased from 7.04 (Mar 23) to 3.34, marking a decrease of 3.70.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 32,847.30. It has increased from 31,130.10 (Mar 23) to 32,847.30, marking an increase of 1,717.20.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.13. This value is within the healthy range. It has increased from 1.85 (Mar 23) to 2.13, marking an increase of 0.28.
  • For EV / EBITDA (X), as of Mar 24, the value is 10.48. This value is within the healthy range. It has increased from 7.71 (Mar 23) to 10.48, marking an increase of 2.77.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.79. This value is within the healthy range. It has increased from 1.48 (Mar 23) to 1.79, marking an increase of 0.31.
  • For Retention Ratios (%), as of Mar 24, the value is -66.41. This value is below the healthy minimum of 30. It has decreased from 86.27 (Mar 23) to -66.41, marking a decrease of 152.68.
  • For Price / BV (X), as of Mar 24, the value is 1.24. This value is within the healthy range. It has decreased from 1.26 (Mar 23) to 1.24, marking a decrease of 0.02.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.79. This value is within the healthy range. It has increased from 1.48 (Mar 23) to 1.79, marking an increase of 0.31.
  • For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 23) to 0.01, marking a decrease of 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Tata Chemicals Ltd as of August 16, 2025 is: 424.52

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of August 16, 2025, Tata Chemicals Ltd is Overvalued by 54.55% compared to the current share price 934.00

Intrinsic Value of Tata Chemicals Ltd as of August 16, 2025 is: 417.18

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of August 16, 2025, Tata Chemicals Ltd is Overvalued by 55.33% compared to the current share price 934.00

Last 5 Year EPS CAGR: -1.73%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a low average Working Capital Days of -4.92, which is a positive sign.
  2. The company has higher reserves (12,938.42 cr) compared to borrowings (7,146.83 cr), indicating strong financial stability.
  3. The company has shown consistent growth in sales (12.75 cr) and profit (125.08 cr) over the years.
  1. The stock has a low average ROCE of 11.00%, which may not be favorable.
  2. The stock has a high average Cash Conversion Cycle of 67.67, which may not be favorable.

Stock Analysis

  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Tata Chemicals Ltd:
    1. Net Profit Margin: 2.37%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 7.01% (Industry Average ROCE: 7.11%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 1.2% (Industry Average ROE: 8.15%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 3.34
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 0.63
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 51.6 (Industry average Stock P/E: 40.18)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0.22
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Tata Chemicals Ltd. is a Public Limited Listed company incorporated on 23/01/1939 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1939PLC002893 and registration number is 002893. Currently Company is involved in the business activities of Manufacture of basic chemicals, fertilizer and nitrogen compounds, plastics and synthetic rubber in primary forms. Company's Total Operating Revenue is Rs. 4441.00 Cr. and Equity Capital is Rs. 255.00 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Chemicals - Inorganic - Caustic Soda/Soda AshBombay House, 24, Homi Mody Street, Mumbai Maharashtra 400001investors@tatachemicals.com
http://www.tatachemicals.com
Management
NamePosition Held
Mr. S PadmanabhanChairman
Mr. R MukundanManaging Director & CEO
Mr. Modan SahaDirector
Mrs. Padmini Khare KaickerIndependent Director
Mr. Rajiv DubeIndependent Director
Dr. C V NatrajIndependent Director
Mr. K B S AnandIndependent Director

FAQ

What is the intrinsic value of Tata Chemicals Ltd?

Tata Chemicals Ltd's intrinsic value (as of 15 August 2025) is ₹424.52 which is 54.55% lower the current market price of ₹934.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹23,782 Cr. market cap, FY2025-2026 high/low of ₹1,247/756, reserves of ₹21,339 Cr, and liabilities of ₹37,750 Cr.

What is the Market Cap of Tata Chemicals Ltd?

The Market Cap of Tata Chemicals Ltd is 23,782 Cr..

What is the current Stock Price of Tata Chemicals Ltd as on 15 August 2025?

The current stock price of Tata Chemicals Ltd as on 15 August 2025 is 934.

What is the High / Low of Tata Chemicals Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Tata Chemicals Ltd stocks is 1,247/756.

What is the Stock P/E of Tata Chemicals Ltd?

The Stock P/E of Tata Chemicals Ltd is 51.6.

What is the Book Value of Tata Chemicals Ltd?

The Book Value of Tata Chemicals Ltd is 847.

What is the Dividend Yield of Tata Chemicals Ltd?

The Dividend Yield of Tata Chemicals Ltd is 1.18 %.

What is the ROCE of Tata Chemicals Ltd?

The ROCE of Tata Chemicals Ltd is 3.96 %.

What is the ROE of Tata Chemicals Ltd?

The ROE of Tata Chemicals Ltd is 1.20 %.

What is the Face Value of Tata Chemicals Ltd?

The Face Value of Tata Chemicals Ltd is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Tata Chemicals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore More Stocks